Standout Papers

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2006 2026 2012 2019 2.4k
  1. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2006)
    Chris H. Polman, Paul O’Connor et al. New England Journal of Medicine
  2. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis (2012)
    Robert J. Fox, David H. Miller et al. New England Journal of Medicine

Immediate Impact

23 from Science/Nature 68 standout
Sub-graph 1 of 19

Citing Papers

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
2021 StandoutNature
1 intermediate paper

Works of J. Theodore Phillips being referenced

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
2012 Standout
Immune surveillance in multiple sclerosis patients treated with natalizumab
2006

Author Peers

Author Last Decade Papers Cites
J. Theodore Phillips 5067 2450 2005 97 7.3k
Hans-Peter Hartung 5071 1668 2660 82 7.4k
Hillel Panitch 5530 1568 2868 95 8.1k
Michael Panzara 7387 3237 2645 78 10.0k
Jan Lycke 3966 1275 1789 144 6.1k
Edward Fox 3509 1485 1498 154 5.8k
Sandra Vukusic 6690 1061 3321 167 8.9k
Stephen L. Hauser 5291 1770 1655 96 9.9k
Klaus Schmierer 4249 1145 1754 170 6.7k
John Rose 3616 978 1763 140 5.8k
D. W. Paty 5939 1202 2305 72 7.6k

All Works

Loading papers...

Rankless by CCL
2026